The Impact of Patient Motivational Dialogue (PMD) on Patient Self-advocacy for Hand Hygiene
NCT ID: NCT04360057
Last Updated: 2020-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2016-10-01
2018-03-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multifaceted Intervention to Improve Hand Hygiene
NCT00375037
Helping Hands: Promoting Hand Hygiene in Hospital Nurses
NCT00548015
Effectiveness of an Alcohol-based Hand Rub to "Clean" Gloved Hands
NCT03445676
How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?
NCT04348227
Evaluation of Two Hand Hygiene Products in ICUs
NCT02258412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
New patients will be enrolled in the study starting September 2016 until the sample size reaches 30 patients per clinic (n=60). Each patient will be followed in each clinic visit longitudinal through March 2017 or until discharged from the clinic treatment depending on which comes first. PMD will be administered in the first clinic visit followed by the PMDPlus each visit thereafter to ensure an adequate treatment dose. The PMD is estimated to take about two minutes of the initial clinic visit and the PMDPlus is estimated to take about one minute of the follow-up clinic visit.
The following steps will be taken based on the innovation decision model:
1. The PI will instruct the physicians, or designee in the use of the PMD/PMDPlus. Script cards with the PMD/PMDPlus will be provided to each physician. The physician will be instructed in use of PMD at the initial visit and the PMDPlus every follow-up clinic visit thereafter until discharge from the clinic.
2. A HCP survey will be conducted pre-intervention asking the HCP: "Has a patient or family ever ask you to clean your hands? If yes, the HCP will be asked to describe the situation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hand Hygiene education
PMD
A script used to train the physician to engage with the patient in the topic of hand hygiene compliance used on the initial visit.
PMDPlus
A script used to train the physician to engage with the patient in the topic of hand hygiene compliance on follow up visits
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PMD
A script used to train the physician to engage with the patient in the topic of hand hygiene compliance used on the initial visit.
PMDPlus
A script used to train the physician to engage with the patient in the topic of hand hygiene compliance on follow up visits
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand instructions given by physician
* Receiving care in radiation oncology clinic and/or chemotherapy clinic at Cancer Therapy Research Center at University of Texas Health Science Center (UTHSCSA)
Exclusion Criteria
3 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center at San Antonio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patti G Grota
Role: PRINCIPAL_INVESTIGATOR
University of Texas Health at San Antonio
Tony Eng, MD
Role: PRINCIPAL_INVESTIGATOR
University of Texas Health at San Antonio
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cancer Therapy & Research Center at UTHSCSA
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC20160369H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.